Cell C's financial woes have weighed on major shareholder Blue Label. Picture: THAPELO MOREBUDI
Blue Label holds a 45% stake in Cell C, which incurred trading losses of R1.56bn during the period, and impairments of R2.2bn. Cell C also de-recognised its deferred tax asset of R4.09bn, Blue Label said on Thursday. Blue Label paid R5.5bn in August 2017 for its stake in Cell C, through its wholly owned subsidiary The Prepaid Company , who’s share of the value-in-use of Cell C was R6.04bn at the start of the period, though this has been reduced to zero.
Excluding these impairments, the group grew its core headline earnings 26% to R904m, and HEPS would have been 98.98c.
United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Blue Label reports R6.6bn loss, more than twice its market capitalisationBlue Label paid R5.5bn in August 2017 for its stake in Cell C, through its wholly owned subsidiary The Prepaid Company.
Read more »
Blue Label reports R6.6bn loss, more than twice its market capitalisationBlue Label paid R5.5bn in August 2017 for its stake in Cell C, through its wholly owned subsidiary The Prepaid Company.
Read more »
Cosatu: Battle against job losses at banks has only been 'postponed, not cancelled' | IOL Business ReportTrade union Sasbo will launch an urgent appeal against the labour court judgment that barred banking sector members from embarking on a strike. Losi(ng) Zingiswa is a puppet and praise singer of number 1 forgetting workers interest
Read more »